Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

UV-radiation induces dose-dependent regulation of p53 response and modulates p53-HDM2 interaction in human fibroblasts

A Corrigendum to this article was published on 11 December 2001

Abstract

We address here the effects of increasing fluencies of UV-radiation on stability, modifications, activity and HDM2-interactions of endogenous p53 tumor suppressor and on cellular damage response of human diploid fibroblasts. Low amounts of UVB/C-radiation induced a transient cell cycle arrest of the cells which correlated with rapid but transient increase in p53 levels. In contrast, high UV-fluency caused cell apoptosis and a slower but sustained increase in p53. Regulation of p53 target genes was highly dependent on the radiation dose used. Whereas low doses induced p21/Cip1/Waf1 and HDM2, high doses induced only GADD45 and BAX increasing the BAX:BCL-2 ratio. The levels of HDM2, a negative regulator of p53, increased only by the low dose of UVC and p53-HDM2 association was promoted. In the absence of HDM2-induction after the high dose of UV-radiation p53-HDM2-interaction was promoted, but HDM2 failed to downregulate p53. p53 site-specific modifications (Ser15, Ser33, Ser37, Lys382) varied kinetically and were dependent on the fluency of the radiation used. Maximal phosphorylation of p53 on Ser15 and Ser33 correlated with increased levels of HDM2-free p53. The results suggest that regulation of p53 and HDM2 by UV-radiation is highly dose-dependent and contributes to the outcome of the cellular response.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Andrews NC, Faller DV . 1991 Nucleic Acids Res. 19: 2499

  • Ashcroft M, Kubbutat MHG, Vousden KH . 1999 Mol. Cell. Biol. 19: 1751–1758

  • Blattner C, Tobiash E, Liften M, Rahmsdorf HJ, Herrlich P . 1999 Oncogene 18: 1723–1732

  • Barak Y, Juven T, Haffner R, Oren M . 1993 EMBO J. 12: 461–468

  • Barley RDC, Enns L, Paterson MC, Mirzayans R . 1998 Oncogene 17: 533–543

  • Buschmann T, Adler V, Matusevich E, Fuchs SY, Ronai Z . 2000 Cancer Res. 60: 896–900

  • Chang D, Chen F, Zhang F, McKay B, Ljungman M . 1999 Cell Growth Differ. 10: 155–162

  • Chao C, Saito S, Anderson CW, Appella E, Xu Y . 2000 Proc. Natl. Acad. Sci. USA 97: 11936–11941

  • Chen J, Marechal V, Levine AJ . 1993 Mol. Cell Biol. 13: 4107–4114

  • Chomczynski P . 1992 Anal. Biochem. 201: 134–139

  • Craig AL, Burch L, Vojtesek B, Mikutowska J, Thompson A, Hupp TR . 1999 Biochem. J. 342: 133–141

  • Dumaz N, Meek DW . 1999 EMBO J. 18: 7002–7010

  • El-Deiry WS . 1998 Semin. Cancer Biol. 8: 345–357

  • El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B . 1993 Cell 75: 817–825

  • Gu W, Roeder RG . 1997 Cell 90: 595–606

  • Haapajärvi T, Pitkänen K, Tsubari M, Laiho M . 1997 Mol. Cell. Biol. 17: 3074–3080

  • Haapajärvi T, Kivinen L, Heiskanen A, des Bordes C, Datto MB, Wang X-F, Laiho M . 1999 Exp. Cell Res. 248: 272–279

  • Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ . 1993 Cell 75: 805–816

  • Haupt Y, Maya R, Kazaz A, Oren M . 1997 Nature 387: 296–299

  • Honda R, Tanaka H, Yasuda H . 1997 FEBS Lett. 420: 25–27

  • Honda R, Yasuda H . 1999 EMBO J. 18: 22–27

  • Juven T, Barak Y, Zauberman A, George DL, Oren M . 1993 Oncogene 8: 3411–3416

  • Kapoor M, Hamm R, Yan W, Taya Y, Lozano G . 2000 Oncogene 19: 358–364

  • Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace Jr AJ . 1992 Cell 71: 587–597

  • Kubbutat MHG, Jones SN, Vousden KH . 1997 Nature 387: 299–303

  • Lambert PF, Kashanchi F, Radonovich MF, Shiekhattar R, Brady JN . 1998 J. Biol. Chem. 273: 33048–33053

  • Lev Bar-Or R, Maya R, Segel LA, Alon U, Levine AJ, Oren M . 2000 Proc. Natl. Acad. Sci. USA 97: 11250–11255

  • Levine AJ . 1997 Cell 88: 323–331

  • Ljungman M, Zhang F, Chen F, Rainbow AJ, McKay B . 1999 Oncogene 18: 583–592

  • Loignon M, Fetni R, Gordon AJE, Drobetsky EA . 1997 Cancer Res. 57: 3390–3394

  • Lu X, Burbidge SA, Griffin S, Smith HM . 1996 Oncogene 13: 413–418

  • Mailand N, Falck J, Lukas C, SyljuÃ¥sen RG, Welcker M, Bartek J, Lukas J . 2000 Science 288: 1425–1429

  • Maki CG, Huibregtse JM, Howley PM . 1996 Cancer Res. 56: 2649–2654

  • Maltzman W, Czyzyk L . 1984 Mol. Cell. Biol. 9: 1689–1694

  • McKay BC, Ljungman M, Rainbow AJ . 1998 Oncogene 17: 545–555

  • Meek DW . 1999 Oncogene 18: 7666–7675

  • Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC . 1994 Oncogene 9: 1799–1805

  • Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T, Nishimori H, Tamai K, Tokino T, Nakamura Y, Taya Y . 2000 Cell 102: 849–862

  • Perry ME, Piette J, Zawadzki JA, Harvey D, Levine AJ . 1993 Proc. Natl. Acad. Sci. 90: 11623–11627

  • Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B . 1997 Nature 305

  • Reinke V, Lozano G . 1997 Rad. Res. 148: 115–122

  • Rodriquez MS, Desterro JMP, Lain S, Lane DP, Hay RT . 2000 Mol. Cell. Biol. 20: 8458–8467

  • Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A, Anderson CW, Appella E . 1998 Genes Dev. 12: 2831–2841

  • Saucedo LJ, Carstens BP, Seavey SE, Albee II LD, Perry ME . 1998 Cell Growth Differ. 9: 119–130

  • Shieh S-Y, Ikeda M, Taya Y, Prives C . 1997 Cell 91: 325–334

  • Shieh S-Y, Taya Y, Prives C . 1999 EMBO J. 18: 1815–1823

  • Shieh S-Y, Ahn J, Tamai K, Taya Y, Prives C . 2000 Genes Dev. 14: 289–300

  • Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E, Kastan MB . 1997 Genes Dev. 11: 3471–3481

  • Thomas A, White E . 1998 Genes Dev. 12: 1975–1985

  • Tyrrell RM . 1994 Mol. Asp. Med. 15: 3–77

  • Unger T, Juven-Gershon T, Moallem E, Berger M, Sionov RV, Lozano G, Oren M, Haupt Y . 1999 EMBO J. 18: 1805–1814

  • Wang XW, Yeh H, Schaeffer L, Roy R, Moncollin V, Egly JM, Wang Z, Freidberg EC, Evans MK, Taffe BG, Bohr VA, Weeda G, Hoeijmakers JHJ, Forrester K, Harris CC . 1995 Nat. Genet. 10: 188–195

  • Wu L, Levine A . 1997 Mol. Med. 3: 441–451

  • Zhao R, Gish K, Murphy M, Yin Y, Notterman D, Hoffman WH, Tom E, Mack DH, Levine AJ . 2000 Genes Dev. 14: 981–993

Download references

Acknowledgements

Annamari Heiskanen is thanked for excellent technical assistance. We thank Leif Andersson for PARP antibody and Toivo Maimets for 2A10 antibody. This study was supported by the Academy of Finland, Centre of Excellence Program (grant no 44895), Biocentrum Helsinki, the Finnish Cancer Organization and the Ida Montin Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marikki Laiho.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Latonen, L., Taya, Y. & Laiho, M. UV-radiation induces dose-dependent regulation of p53 response and modulates p53-HDM2 interaction in human fibroblasts. Oncogene 20, 6784–6793 (2001). https://doi.org/10.1038/sj.onc.1204883

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204883

Keywords

This article is cited by

Search

Quick links